530 results about "Subcutaneous fat" patented technology

A method and apparatus are provided for targeting lipid-rich tissue to effect a desired, the method / apparatus involving irradiating the lipid-rich tissue with energy at a wavelength preferentially absorbed by lipid cells, such wavelength being preferably in a band between 880 nm and 935 nm, 1150 nm and 1230 nm, 1690 nm to 1780 nm, or 2250 nm to 2450 nm with a fluence and duration sufficient to achieve a desired treatment. For preferred embodiments, the irradiation wavelength is between 900–930 nm, 1190–1220 nm, 1700–1730 nm, or 2280–2350 nm. The method and apparatus may for example be used to target one or more sebaceous glands for the treatment of acne or hair removal, to target subcutaneous fat for removal thereof or for targeting fat on anatomical elements for various purposes.

A method of wound closure comprising providing a gold suture and closing the laceration with the gold suture. The laceration is closed by: inserting the suture into the dermis and through the subcutaneous fat layer on one side of the laceration; inserting the suture at the base of the laceration; inserting the suture through the subcutaneous fat layer and into the dermis on the other side of the laceration to form a loop under the skin; repeating the steps in another insertion 3 to 5 mm from the loop in a continuous or interrupted manner to close the laceration; and tightening the suture line by applying tension to the loops to bring one side of the laceration into contact with the other side of the laceration.

An apparatus and method for performing non-invasive treatment of the human face and body by electroporation in lieu of cosmetic surgery is provided. The apparatus comprises a high voltage pulse generator and an applicator having two or more electrodes in close mechanical and electrical contact with the patient's skin for applying the pulses to the patient's skin. The applicator may consist of two pieces with one electrode having a sharp tip and another having a flat surface. High voltage pulses delivered to the electrodes create at the tip of the sharp electrode an electric field high enough to cause death of relatively large subcutaneous fat cells by electroporation. Moving the electrode tip along the skin creates a line of necrotic subcutaneous fat cells, which later are metabolized by the body. Multiple applications of the electrode along predetermined lines on the face or neck create shrinkage of the skin and the subcutaneous fat volume underlying the treated area.

An apparatus and method for treating subcutaneous tissues using acoustic waves in the range of low acoustic pressure ultrasound waves is disclosed. The method includes injections of enhancing agents, wherein disruption of subcutaneous tissues and subcutaneous cavitational bioeffects are produced by ultrasound waves having a power that will not produce tissue cavitation in the absence of the enhancing agents. The apparatus and method of use is useful for treatment of subcutaneous abnormalities including cellulite, lipomas, and tumors.

The present invention provides a synthetic, poorly crystalline apatite (PCA) calcium phosphate containing a biologically active agent and / or cells (preferably tissue-forming or tissue-degrading cells). The compositions provided by the present invention are useful for a variety of in vivo and in vitro applications, including drug delivery (for example, to bony sites, the central nervous system, intramuscular sites, subcutaneous sites, interperitoneal sites, and occular sites) tissue growth (preferably bone or cartilage) osseous augmentation, and methods of diagnosing disease states by assaying tissue forming potential of cells isolated from a host. The invention also provides methods of preparing delivery vehicles, of altering delivery vehicle characteristics, and of delivering biologically active agents to a site. The invention further provides in vitro cell culture systems and cell encapsulation materials. The invention is useful for both medical and veterinary applications.

A method of implanting an injection port using the step of providing an injection port having a housing having a body, a fluid reservoir, a needle penetrable septum, and at least one stabilizing element mounted to the housing comprising a member having an undeployed position and a deployed position, wherein the stability element extends radially from the body. The method further involves the step of creating a surgical incision through the skin and subcutaneous fat layers of the patient to expose the fascia, and placing the injection port between the subcutaneous fat layer and the fascia tissue. The method even further involves the step of deploying the stability element.

A treatment of sweat glands in a target region of skin includes generating electromagnetic radiation having a wavelength of about 1,064 nm to about 1,800 nm. To decrease sweat production in a plurality of sweat glands, the electromagnetic radiation is delivered to a dermal interface defined by a dermal region and a subcutaneous fat region in the target region of skin to cause thermal injury to at least one of the dermal region, the subcutaneous fat region or the dermal interface. An epidermal region of the skin can be cooled at least one of before, during or after delivering the electromagnetic radiation to the dermal interface in the target region of skin.

The invention provides a system and method for processing medical images. Input medical images are normalized first, utilizing pixel intensities of control point tissues, including subcutaneous fat. Clustered density map and malignance probability map are generated from a normalized image and further analyzed to identify regions of common internal characteristics, or blobs, that may represent lesions. These blobs are analyzed and classified to differentiate possible true lesions from other types of non-malignant masses often seen in medical images.

The disclosure provides a method and apparatus for noninvasive and minimally-invasive treatment of skin and subcutaneous tissues with ultrasound with or without nano- or microparticles. The treatment includes, but is not limited to, hair removal, skin rejuvenation (wrinkle removal), scar removal, treatment of spider veins and varicose veins, removal of birthmarks, acne treatment, wound treatment, abnormal pigmentation and stretch mark removal, abnormal tissues in skin and subcutaneous layers, and tattoo removal. Skin and subcutaneous tissues which can be treated with the methods described include, but are not limited to, the dermis, epidermis, subcutaneous fat, connective tissue, muscle tissue, blood vessels, scar tissues, tendons, and cartilage tissues, and abnormal tissues in skin and subcutaneous layers. The disclosure is especially applicable to hair removal and skin rejuvenation.

The present invention provides an apparatus and method of body contouring and skin conditioning using a mobile handpiece 16. The mobile handpiece 16 treats cellulite and the like by producing vibrations in the subcutaneous layers of fat. A cup 18 of the mobile handpiece 16 is placed against the skin to create a chamber 60. A vacuum source 160 and compressor 162, which are in communication with chamber 60, are then controlled to produce an oscillating pressure within the chamber 60. This vibration of the skin surface is transferred through the dermal layers thereby influencing fluid retention and cellulite build up.

A percutaneous cellulite removal needle of the present invention can be used to make the appearance of cellulite less obvious by cutting the fibrous bridges that connect the skin to muscle / fascia or fibrous septae in the subcutaneous fat in a minimally invasive manner. The percutaneous cellulite removal needle of the present invention preferably includes a body having an internal chamber that ends at a laterally disposed aperture. A cutting mechanism is substantially positioned within the internal chamber in a retracted position and at least partially protrudes through the laterally disposed aperture in a cutting position. A situating mechanism transitions the cutting mechanism between the retracted position and the cutting position. The present invention also includes a method in which the percutaneous cellulite removal needle is inserted through the skin with the cutting mechanism in the retracted position. The cutting mechanism is then extruded so that the cutting mechanism is in the cutting position. Next the cutting mechanism is actuated, for example by rotating, to cut at least one the fibrous bridge or septae. These steps may be repeated to cut other fibrous bridges or septae reachable by the cutting mechanism. The cutting mechanism is then retracted and the percutaneous cellulite removal needle is removed.

Disclosed is a method for measuring subcutaneous fat using an ultrasonic wave, comprising a step of measuring a portion of an abdomen on a median line of a person under test. The present invention also provides an apparatus for measuring subcutaneous fat using an ultrasonic wave. The apparatus comprises: a reference position setting device which sets said apparatus at a reference position for measurement on a person under test; an ultrasonic transmitter disposed at the predetermined position relative to said reference position setting device; and an ultrasonic receiver disposed at the predetermined position relative to said reference position setting device. According to the present invention, a navel of the person is defined as the reference position for measurement. The area to be measured on the abdomen of the person is located along the median line between the sternum and the pubis of the person. Furthermore, the ultrasonic transmitter and the ultrasonic receiver are disposed for measuring the subcutaneous fat in a position around 2 cm above the navel of the person along a median line.

In accordance with the present invention, there is provided a method for subcutaneously implanting an injection port for use with an implantable medical device. The method involves providing an injection port comprising an elongated flexible substantially non-rigid body having first and second ends and a wall therebetween, the wall is such that it will self seal after being punctured, the body further including and a fluid reservoir surrounded by the wall and a flexible elongated tubular catheter attached to the body which is in fluid communication with the reservoir. Thereafter, the method involves creating an incision within the patient, accessing the subcutaneous fat layer of the patient through the incision, creating a space in the subcutaneous fat layer and implanting the injection port within the subcutaneous fat layer such that the port can be found externally by palpitation.

A treatment for subcutaneous fat and / or cellulite includes delivering a beam of radiation to a subcutaneous fat region disposed relative to a dermal interface in a target region of skin. The beam of radiation affects at least one fat cell in the subcutaneous fat region without causing substantial unwanted injury to the epidermal region and causes thermal injury to a dermal region to induce collagen formation to strengthen the target region of skin in a target region of skin. The treatment can include cooling an epidermal region of the target region of skin.

A non-abusable, non-inflammatory, biocompatible, non-biodegradable, subcutaneous, polymeric implant for the prolonged, controlled release of hydromorphone with near zero-order kinetics is described. Methods of alleviating cancer pain and treating opioid drug addiction with the implant are also described.

The present invention relates to a new and improved method for preparing a highly concentrated immunoglobulin composition from pooled plasma for subcutaneous injection. A composition comprising 20% or more immunoglobulin suitable for subcutaneous use is also described.

Methods for focused remodeling and downsizing the volume of subcutaneous lipid-rich cells, body contouring, and tightening skin tissue, using controlled heating of the targeted areas on the body. The electromagnetic energy heats the. subcutaneous tissues which provides the desired effect. The electromagnetic energy is applied via an applicator without touching the skin. A spacer of insulating or dielectric material may be provided between the applicator and the skin.

A percutaneous cellulite removal needle of the present invention can be used to make the appearance of cellulite less obvious by cutting the fibrous bridges that connect the skin to muscle / fascia or fibrous septae in the subcutaneous fat in a minimally invasive manner. The percutaneous cellulite removal needle of the present invention preferably includes a body having an internal chamber that ends at a laterally disposed aperture. A cutting mechanism is substantially positioned within the internal chamber in a retracted position and at least partially protrudes through the laterally disposed aperture in a cutting position. A situating mechanism transitions the cutting mechanism between the retracted position and the cutting position. The present invention also includes a method in which the percutaneous cellulite removal needle is inserted through the skin with the cutting mechanism in the retracted position. The cutting mechanism is then extruded so that the cutting mechanism is in the cutting position. Next the cutting mechanism is actuated, for example by rotating, to cut at least one the fibrous bridge or septae. These steps may be repeated to cut other fibrous bridges or septae reachable by the cutting mechanism. The cutting mechanism is then retracted and the percutaneous cellulite removal needle is removed.

A subcutaneous implantable cardioverter-defibrillator which has an electrically active canister which houses a source of electrical energy, a capacitor, and operational circuitry that senses the presence of potentially fatal heart rhythms delivers cardioversion defibrillation energy between at least one subcutaneous lead and the electrically active canister. There are no transvenous, intracardiac, or epicardial electrodes. The electrically active canister and at least one lead is implanted utilizing a curved introducer to implant the electrically active canister subcutaneously at various locations around the thorax.

Methods for focused remodeling and downsizing the volume of subcutaneous lipid-rich cells, body contouring, and tightening skin tissue, using controlled heating of the targeted areas on the body. The electromagnetic energy heats the subcutaneous tissues which provides the desired effect. The electromagnetic energy is applied via an applicator without touching the skin. A spacer of insulating or dielectric material may be provided between the applicator and the skin.

The invention describes a treatment for skin wherein a pattern of holes is ablated in a selected region of skin tissue using an optical source. Substantially nonablative energy is delivered to the selected region to at least two holes in the pattern to thermally heat a target in or just beneath the skin, such as hair follicles, sebaceous glands, or subcutaneous fat. The invention may further be improved by adding a feedback mechanism that adapts the nonablative energy in response to a measurement enabled by the ablation of holes. The apparatus may include a positional sensor to provide additional dosage control, particularly when the inventive method is used with a continuously movable handpiece.

The present invention features methods of manipulating subdermal fat in a treatment area. Such methods include inserting a needle (e.g., a micro-coring needle) through the dermis to the subdermal fat layer in order to excise a portion of tissue from the treatment area. These insertions result in a portion of the dermis and a portion of subdermal fat to enter into the needle. Removal of the needle results in excision of the portion of dermis and subdermal fat that entered into the needle.

A treatment for subcutaneous fat and / or cellulite includes delivering a beam of radiation to a subcutaneous fat region disposed relative to a dermal interface in a target region of skin. The beam of radiation affects at least one fat cell in the subcutaneous fat region without causing substantial unwanted injury to the epidermal region and causes thermal injury to a dermal region to induce collagen formation to strengthen the target region of skin in a target region of skin. The treatment can include cooling an epidermal region of the target region of skin.

The present invention provides an apparatus and method of body contouring and skin conditioning. The apparatus 10 treats cellulite and the like by producing vibrations in the subcutaneous layers of fat. A cup 18 of handpiece 16 is placed against the skin to create a chamber 60. A vacuum source 160 and compressor 162, which are in communication with chamber 60, are then controlled to produce an oscillating pressure within the chamber 60. This vibration of the skin surface is transferred through the dermal layers thereby influencing fluid retention and cellulite build up.

The invention relates to a method and apparatus for locating and tracking persons by use of an implantable device. The described invention is an implant able device composed of biocompatible materials in all areas where contact with organic tissue occurs. The gross anatomic siting of the device includes any limb, the torso, including back and perineum, the neck, and the head. The surgical anatomic siting of the device includes: (1) Supramuscular: for example, deep to the epidermis, dermis, and subcutaneous fat, on or attached to muscle and / or muscle fascia. Such a location is currently used for implantation of commercially available buried intravenous access ports, which are positioned on, and attached to, the pectoralis major muscle fascia; (2) Intramuscular: for example, within or between the muscles of a limb; (3) Submuscular: for example, deep to a large muscle. Such a location is currently used for implantation of commercially available artificial urethral and anal sphincter reservoirs, which are positioned deep to the rectus abdominus muscles, within the pre-peritoneal Space of Retzius; (4) Intraluminal: for example, within the lumen of an organ which has a naturally occurring orifice. Such a location is currently used for implantation of commercially available ingested video endoscopy capsule devices, i.e. gastrointestinal tract lumen, and intrauterine contraceptive devices, i.e. uterus lumen; and (5) Intracavitary: for example, intrathoracic or intraperitoneal. Such an intraperitoneal location is currently used for implantation of commercially available intraperitoneal dialysis catheters.

To accurately acquire body composition information using data acquired by another device. Thus, there is provided a body composition monitor with scale including a communication unit for allowing input of biological component information (cross-sectional area, site length, subcutaneous fat percentage, visceral fat percentage, etc.) of a living body measured with another device such as an MRI, where step of calculating the body composition of the living body based on the biological component information, an impedance detected by an impedance detection unit, and a weight measured by a load detection unit is executed.

Two current electrodes 2 and 3 are arranged on a circumference of a subject 1, a distance between the two current electrodes being sufficiently shorter than a circumferential length of the subject 1. A current source 4 passes a current between the two current electrodes. A measuring electrode 5 is arranged adjacent to one of the two current electrodes 2 and 3. A measuring electrode 11 is arranged substantially opposite to the two current electrodes 2 and 3 across the subject 1. A voltmeter 7 measures a voltage generated between the measuring electrodes 5 and 11. A body fat computing unit 25 computes the quantity of subcutaneous fat 8 of the subject 1 according to the voltage measured with the voltmeter 7.

The present invention describes compositions and methods for treating, preventing and improving the appearance of skin, particularly, treating, preventing, ameliorating, reducing and / or eliminating loss of subcutaneous fat in the skin, wherein the compositions include natural plant constituents that stimulate lipid synthesis. The plant extracts are preferably derived from Rhinacanthus nasutus, Humulus scandens, Sesbania grandiflora, Amorphophallus campanulatu, Pouzolzia pentandra, and Piper betel, and any combinations thereof . The compositions are preferably applied to the skin, or are delivered by directed means, to a site in need thereof.